Literature DB >> 3142567

Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease.

L Lind1, S Jakobsson, H Lithell, B Wengle, S Ljunghall.   

Abstract

Data from a health screening survey with over 18,000 adult participants were used to determine the relations between serum calcium concentration and the cardiovascular risk factors hypertension, hyperglycaemia, and hyperlipidaemia. Blood pressure and serum glucose and cholesterol concentrations were all positively related to each other independent of age, sex, kidney function, and obesity. Similar relations between the risk factors were found in subjects with hypertension or hyperglycaemia independent of the degree of overweight. These results suggested that there might be a metabolic syndrome of cardiovascular risk factors. Serum calcium concentration was positively related to systolic and diastolic blood pressures and serum glucose and cholesterol concentrations. Thus a common feature in the syndrome is an increased serum calcium concentration. The relations between serum calcium concentrations and the cardiovascular risk factors were not limited to the upper parts of the distribution, being seen over a wide range. Changes in calcium metabolism seem to be related to a metabolic syndrome of hypertension, impaired glucose tolerance, and hyperlipidaemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142567      PMCID: PMC1834646          DOI: 10.1136/bmj.297.6654.960

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  34 in total

1.  Multivariate analysis of risk factors for coronary heart disease.

Authors:  L Wilhelmsen; H Wedel; G Tibblin
Journal:  Circulation       Date:  1973-11       Impact factor: 29.690

2.  Calcium and blood pressure.

Authors:  H Kesteloot; J Geboers
Journal:  Lancet       Date:  1982-04-10       Impact factor: 79.321

3.  Comparison of energy and nutrient intakes in women with high and low blood pressure levels.

Authors:  T Thulin; M Abdulla; I Dencker; M Jägerstad; A Melander; A Nordén; B Scherstén; B Akesson
Journal:  Acta Med Scand       Date:  1980

4.  Detection and characterization of middle-aged men with hypertension.

Authors:  H Hedstrand; H Aberg
Journal:  Acta Med Scand       Date:  1976

5.  Coronary risk factors in a community. Findings in Tecumseh, Michigan.

Authors:  L D Ostrander; D E Lamphiear
Journal:  Circulation       Date:  1976-01       Impact factor: 29.690

6.  The relationship between blood pressure and biochemical risk factors in a general population.

Authors:  C J Bulpitt; C Hodes; M G Everitt
Journal:  Br J Prev Soc Med       Date:  1976-09

7.  Abnormal sodium efflux in erythrocytes of patients with essential hypertension.

Authors:  U Walter; A Distler
Journal:  Hypertension       Date:  1982 Mar-Apr       Impact factor: 10.190

Review 8.  Prevalence of hypercalcaemia in a health survey: a 14-year follow-up study of serum calcium values.

Authors:  M Palmér; S Jakobsson; G Akerström; S Ljunghall
Journal:  Eur J Clin Invest       Date:  1988-02       Impact factor: 4.686

9.  Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak.

Authors:  D A McCarron; P A Pingree; R J Rubin; S M Gaucher; M Molitch; S Krutzik
Journal:  Hypertension       Date:  1980 Mar-Apr       Impact factor: 10.190

10.  Body composition, metabolic and hormonal characteristics in unselected male hypertensives.

Authors:  G Berglund; O Andersson
Journal:  Int J Obes       Date:  1981
View more
  23 in total

1.  Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study.

Authors:  Rolf Jorde; Henrik Schirmer; Inger Njølstad; Maja-Lisa Løchen; Ellisiv Bøgeberg Mathiesen; Elena Kamycheva; Yngve Figenschau; Guri Grimnes
Journal:  Eur J Epidemiol       Date:  2013-07-17       Impact factor: 8.082

2.  Calcium and phosphate concentrations and future development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study.

Authors:  Carlos Lorenzo; Anthony J Hanley; Marian J Rewers; Steven M Haffner
Journal:  Diabetologia       Date:  2014-04-26       Impact factor: 10.122

3.  Cardiometabolic Proteins Associated with Metabolic Syndrome.

Authors:  Lars Lind; Sölve Elmståhl; Erik Ingelsson
Journal:  Metab Syndr Relat Disord       Date:  2019-03-18       Impact factor: 1.894

4.  Calcium levels on admission and before discharge are associated with mortality risk in hospitalized patients.

Authors:  Amit Akirov; Alexander Gorshtein; Ilana Shraga-Slutzky; Ilan Shimon
Journal:  Endocrine       Date:  2017-06-30       Impact factor: 3.633

5.  Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort.

Authors:  E Hagström; P Hellman; E Lundgren; L Lind; J Arnlöv
Journal:  Diabetologia       Date:  2006-12-20       Impact factor: 10.122

6.  Determinants of serum calcium in men and women. The Tromsø Study.

Authors:  R Jorde; J Sundsfjord; K H Bønaa
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

7.  Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

Authors:  E Ferrannini; S M Haffner; B D Mitchell; M P Stern
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

Review 8.  Circulating vitamin D, calcium and risk of cerebrovascular disease: a systematic review and meta-analysis.

Authors:  Rajiv Chowdhury; Sarah Stevens; Heather Ward; Susmita Chowdhury; Ayesha Sajjad; Oscar H Franco
Journal:  Eur J Epidemiol       Date:  2012-09-09       Impact factor: 8.082

9.  Serum ionised calcium and cardiovascular disease in 45-years old men and women followed for 18 years.

Authors:  Christina Gerlach Ogard; Janne Petersen; Torben Jørgensen; Thomas Almdal; Henrik Vestergaard
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

10.  Acute effects of calcium supplements on blood pressure: randomised, crossover trial in postmenopausal women.

Authors:  E O Billington; S M Bristow; G D Gamble; J A de Kwant; A Stewart; B V Mihov; A M Horne; I R Reid
Journal:  Osteoporos Int       Date:  2016-08-20       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.